$3.890
-0.226 (-5.81%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Oramed Pharmaceuticals Inc (ORMP) Moving Averages Convergence Divergence (MACD) indicator is -0.12, suggesting ORMP is Strong sell.
Oramed Pharmaceuticals Inc (ORMP) 20-Day simple moving average is 4.13, while Oramed Pharmaceuticals Inc (ORMP) share price is $—, making it Sell.
Oramed Pharmaceuticals Inc (ORMP) 60-Day simple moving average is 4.54, while Oramed Pharmaceuticals Inc (ORMP) share price is $—, making it Sell.
Technical Analysis for ORMP
AI Technical ORMPAs of 2026-11-03, the technical board for Oramed Pharmaceuticals Inc (ORMP) reads strong sell: 2 indicators are flashing buy, 8 are indicating sell, and 3 are neutral. Price at $3.89 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 34.234, MACD stands at -0.12 (Sell), Stochastic %K stands at 29.167, Stochastic %D stands at 34.722 and CCI stands at -187.289 (Buy).
ORMP trades below the 60-day SMA (4.54) and below the 200-day SMA (4.04). Immediate resistance sits at Classic R1 4.29, then R2 4.49. Support sits at Classic S1 3.89, then S2 3.69.
Oramed Pharmaceuticals Inc (ORMP) Support & Resistance Level
Oramed Pharmaceuticals Inc (ORMP) Technical Indicators
2026-11-03
| Name | Value |
|---|---|
| RSI_14 | 34.234 |
| STOCHk_14_3_3 | 29.167 |
| STOCHd_14_3_3 | 34.722 |
| CCI_20 | -187.289 |
| AO_5_34 | -0.268 |
| MOM_10 | -0.230 |
| MACD_12_26_9 | -0.120 |
Oramed Pharmaceuticals Inc (ORMP) Relative Strength Index (RSI_14) is 34.234, creating a Neutral signal.
Oramed Pharmaceuticals Inc (ORMP) Stochastic %K is 29.167, creating a Neutral signal.
Oramed Pharmaceuticals Inc (ORMP) Stochastic %D is 34.722, creating a Neutral signal.
Oramed Pharmaceuticals Inc (ORMP) CCI_20 is -187.289, creating a Buy signal.
Oramed Pharmaceuticals Inc (ORMP) Awesome Oscillator (AO) is -0.268, creating a Sell signal.
Oramed Pharmaceuticals Inc (ORMP) Momentum (MOM) is -0.230, creating a Sell signal.
Oramed Pharmaceuticals Inc (ORMP) Moving Average Convergence Divergence (MACD) is -0.120, creating a Sell signal.
Oramed Pharmaceuticals Inc (ORMP) Moving Average
2026-11-03
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 4.026 | Sell |
| MA_10 | 4.089 | Sell |
| MA_20 | 4.126 | Sell |
| MA_60 | 4.538 | Sell |
| MA_200 | 4.041 | Sell |
| MA_250 | 3.813 | Buy |
Oramed Pharmaceuticals Inc (ORMP) 5-Day simple moving average is 4.026, while Oramed Pharmaceuticals Inc (ORMP) share price is $, making it a Sell.
Oramed Pharmaceuticals Inc (ORMP) 10-Day simple moving average is 4.089, while Oramed Pharmaceuticals Inc (ORMP) share price is $, making it a Sell.
Oramed Pharmaceuticals Inc (ORMP) 20-Day simple moving average is 4.126, while Oramed Pharmaceuticals Inc (ORMP) share price is $, making it a Sell.
Oramed Pharmaceuticals Inc (ORMP) 60-Day simple moving average is 4.538, while Oramed Pharmaceuticals Inc (ORMP) share price is $, making it a Sell.
Oramed Pharmaceuticals Inc (ORMP) 200-Day simple moving average is 4.041, while Oramed Pharmaceuticals Inc (ORMP) share price is $, making it a Sell.
Oramed Pharmaceuticals Inc (ORMP) 250-Day simple moving average is 3.813, while Oramed Pharmaceuticals Inc (ORMP) share price is $, making it a Buy.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.